- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 36 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 57 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.2: 3 residues within 4Å:- Chain A: F.49, V.185, N.187
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.5: 4 residues within 4Å:- Chain A: N.301, S.408, T.410, W.413
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.6: 3 residues within 4Å:- Chain A: N.330, D.337, Q.347
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.7: 6 residues within 4Å:- Chain A: L.325, Y.327, V.335, L.336, N.354, H.361
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.8: 3 residues within 4Å:- Chain A: N.358, S.533, S.535
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.11: 3 residues within 4Å:- Chain A: N.486, N.510, I.527
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.12: 2 residues within 4Å:- Chain A: N.506, K.532
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.13: 2 residues within 4Å:- Chain A: N.510, N.512
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.14: 1 residues within 4Å:- Chain A: N.626
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.18: 4 residues within 4Å:- Chain A: N.723
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.31, NAG-NAG-BMA-MAN-MAN-MAN-MAN.31, NAG-NAG-BMA-MAN-MAN-MAN-MAN.31
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.19: 2 residues within 4Å:- Chain A: R.746, N.749
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.21: 3 residues within 4Å:- Chain A: N.768, L.968, D.1137
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.22: 2 residues within 4Å:- Chain A: N.844, R.860
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.24: 4 residues within 4Å:- Chain A: Q.999, E.1002, Y.1106, N.1111
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:E.1002
NAG-NAG-BMA-MAN-MAN-MAN-MAN.26: 3 residues within 4Å:- Chain A: V.1197, F.1199, N.1201
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.29: 1 residues within 4Å:- Chain A: N.203
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.30: 2 residues within 4Å:- Chain A: N.52, Q.53
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.31: 3 residues within 4Å:- Chain A: N.98, Q.135
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.18
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.35: 8 residues within 4Å:- Chain A: Y.82, R.110, N.111, T.112
- Ligands: NAG-NAG-BMA-MAN-MAN.33, NAG-NAG-BMA-MAN-MAN.33, NAG-NAG-BMA-MAN-MAN.33, NAG-NAG-BMA-MAN-MAN.33
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.39: 3 residues within 4Å:- Chain B: F.49, V.185, N.187
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.42: 4 residues within 4Å:- Chain B: N.301, S.408, T.410, W.413
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.43: 3 residues within 4Å:- Chain B: N.330, D.337, Q.347
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.44: 6 residues within 4Å:- Chain B: L.325, Y.327, V.335, L.336, N.354, H.361
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.45: 3 residues within 4Å:- Chain B: N.358, S.533, S.535
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.48: 3 residues within 4Å:- Chain B: N.486, N.510, I.527
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.49: 3 residues within 4Å:- Chain B: A.491, N.506, K.532
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.50: 2 residues within 4Å:- Chain B: N.510, N.512
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.51: 1 residues within 4Å:- Chain B: N.626
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.55: 4 residues within 4Å:- Chain B: N.723
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.68, NAG-NAG-BMA-MAN-MAN-MAN-MAN.68, NAG-NAG-BMA-MAN-MAN-MAN-MAN.68
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.56: 2 residues within 4Å:- Chain B: R.746, N.749
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.746
NAG-NAG-BMA-MAN-MAN-MAN-MAN.58: 3 residues within 4Å:- Chain B: N.768, L.968, D.1137
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.59: 2 residues within 4Å:- Chain B: N.844, R.860
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.61: 4 residues within 4Å:- Chain B: Q.999, E.1002, Y.1106, N.1111
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:E.1002
NAG-NAG-BMA-MAN-MAN-MAN-MAN.63: 3 residues within 4Å:- Chain B: V.1197, F.1199, N.1201
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.66: 1 residues within 4Å:- Chain B: N.203
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.67: 2 residues within 4Å:- Chain B: N.52, Q.53
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.68: 3 residues within 4Å:- Chain B: N.98, Q.135
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.55
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.72: 8 residues within 4Å:- Chain B: Y.82, R.110, N.111, T.112
- Ligands: NAG-NAG-BMA-MAN-MAN.70, NAG-NAG-BMA-MAN-MAN.70, NAG-NAG-BMA-MAN-MAN.70, NAG-NAG-BMA-MAN-MAN.70
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.76: 3 residues within 4Å:- Chain C: F.49, V.185, N.187
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.79: 4 residues within 4Å:- Chain C: N.301, S.408, T.410, W.413
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.80: 3 residues within 4Å:- Chain C: N.330, D.337, Q.347
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.81: 6 residues within 4Å:- Chain C: L.325, Y.327, V.335, L.336, N.354, H.361
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.82: 3 residues within 4Å:- Chain C: N.358, S.533, S.535
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.85: 3 residues within 4Å:- Chain C: N.486, N.510, I.527
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.86: 3 residues within 4Å:- Chain C: A.491, N.506, K.532
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.87: 2 residues within 4Å:- Chain C: N.510, N.512
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.88: 1 residues within 4Å:- Chain C: N.626
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.92: 4 residues within 4Å:- Chain C: N.723
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.105, NAG-NAG-BMA-MAN-MAN-MAN-MAN.105, NAG-NAG-BMA-MAN-MAN-MAN-MAN.105
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.93: 2 residues within 4Å:- Chain C: R.746, N.749
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.95: 3 residues within 4Å:- Chain C: N.768, L.968, D.1137
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.96: 2 residues within 4Å:- Chain C: N.844, R.860
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.98: 4 residues within 4Å:- Chain C: Q.999, E.1002, Y.1106, N.1111
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:E.1002
NAG-NAG-BMA-MAN-MAN-MAN-MAN.100: 3 residues within 4Å:- Chain C: V.1197, F.1199, N.1201
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.103: 1 residues within 4Å:- Chain C: N.203
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.104: 3 residues within 4Å:- Chain C: N.52, Q.53, N.178
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.105: 3 residues within 4Å:- Chain C: N.98, Q.135
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.92
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.109: 8 residues within 4Å:- Chain C: Y.82, R.110, N.111, T.112
- Ligands: NAG-NAG-BMA-MAN-MAN.107, NAG-NAG-BMA-MAN-MAN.107, NAG-NAG-BMA-MAN-MAN.107, NAG-NAG-BMA-MAN-MAN.107
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.3: 7 residues within 4Å:- Chain A: L.238, N.240, V.292, R.380, T.381, Q.383, Y.385
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.40: 7 residues within 4Å:- Chain B: L.238, N.240, V.292, R.380, T.381, Q.383, Y.385
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.77: 7 residues within 4Å:- Chain C: L.238, N.240, V.292, R.380, T.381, Q.383, Y.385
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- NAG- GAL- MAN- NAG- GAL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-NAG-GAL-MAN-NAG-GAL.4: 3 residues within 4Å:- Chain A: Y.274, N.276, T.278
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-NAG-GAL-MAN-NAG-GAL.41: 3 residues within 4Å:- Chain B: Y.274, N.276, T.278
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-NAG-GAL-MAN-NAG-GAL.78: 3 residues within 4Å:- Chain C: Y.274, N.276, T.278
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.10: 10 residues within 4Å:- Chain A: E.147, Y.166, K.167, N.426, S.428, Q.433, N.434
- Chain C: S.647, L.648, A.649
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.47: 10 residues within 4Å:- Chain A: S.647, L.648, A.649
- Chain B: E.147, Y.166, K.167, N.426, S.428, Q.433, N.434
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.84: 10 residues within 4Å:- Chain B: S.647, L.648, A.649
- Chain C: E.147, Y.166, K.167, N.426, S.428, Q.433, N.434
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- NAG- GAL- NAG- GAL- MAN- NAG- GAL- FUC: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-L-fucopyranose-(1-6)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG-GAL-FUC.27: 2 residues within 4Å:- Chain A: N.1218, Q.1222
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG-GAL-FUC.64: 2 residues within 4Å:- Chain B: N.1218, Q.1222
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG-GAL-FUC.101: 3 residues within 4Å:- Chain A: Y.1231
- Chain C: N.1218, Q.1222
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.33: 17 residues within 4Å:- Chain A: V.57, A.76, H.78, G.80, Y.81, Y.82, Y.90, F.108, N.111, T.112, T.113, F.114, D.115, N.119
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.35, NAG-NAG-BMA-MAN-MAN-MAN-MAN.35, NAG-NAG-BMA-MAN-MAN-MAN-MAN.35
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Y.82, A:H.78, A:N.111
- Hydrophobic interactions: A:F.114
NAG-NAG-BMA-MAN-MAN.70: 17 residues within 4Å:- Chain B: V.57, A.76, H.78, G.80, Y.81, Y.82, Y.90, F.108, N.111, T.112, T.113, F.114, D.115, N.119
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.72, NAG-NAG-BMA-MAN-MAN-MAN-MAN.72, NAG-NAG-BMA-MAN-MAN-MAN-MAN.72
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Y.82, B:H.78, B:N.111
- Hydrophobic interactions: B:F.114
NAG-NAG-BMA-MAN-MAN.107: 17 residues within 4Å:- Chain C: V.57, A.76, H.78, G.80, Y.81, Y.82, Y.90, F.108, N.111, T.113, F.114, D.115, N.119, K.174
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.109, NAG-NAG-BMA-MAN-MAN-MAN-MAN.109, NAG-NAG-BMA-MAN-MAN-MAN-MAN.109
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:Y.82, C:H.78, C:H.78, C:N.111
- Hydrophobic interactions: C:F.114
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.37: 3 residues within 4Å:- Chain A: G.495, S.496, H.503
No protein-ligand interaction detected (PLIP)NAG-NAG.74: 3 residues within 4Å:- Chain B: G.495, S.496, H.503
No protein-ligand interaction detected (PLIP)NAG-NAG.111: 3 residues within 4Å:- Chain C: G.495, S.496, H.503
No protein-ligand interaction detected (PLIP)- 8 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-4)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.112: 3 residues within 4Å:- Chain B: F.1241, N.1242, L.1243
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.113: 1 residues within 4Å:- Chain C: N.1242
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.114: 3 residues within 4Å:- Chain A: F.1236, D.1237, N.1242
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.115: 7 residues within 4Å:- Chain A: D.1237, L.1243, N.1247, S.1250
- Chain C: N.1247, L.1248, E.1251
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:E.1251
- Hydrophobic interactions: A:L.1243
NAG-NAG-BMA-MAN-MAN-MAN-MAN.116: 4 residues within 4Å:- Chain B: Y.1245, L.1248
- Chain C: L.1246, N.1247
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.117: 2 residues within 4Å:- Chain C: D.1274, N.1277
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.118: 3 residues within 4Å:- Chain A: N.1277, V.1281
- Chain B: Q.1275
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.119: 2 residues within 4Å:- Chain B: N.1277, V.1281
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chmielewski, D. et al., A hinge glycan regulates spike bending and impacts coronavirus infectivity. To Be Published
- Release Date
- 2023-10-04
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
B
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 36 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 57 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- NAG- GAL- MAN- NAG- GAL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- NAG- GAL- NAG- GAL- MAN- NAG- GAL- FUC: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-L-fucopyranose-(1-6)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-4)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chmielewski, D. et al., A hinge glycan regulates spike bending and impacts coronavirus infectivity. To Be Published
- Release Date
- 2023-10-04
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
B